The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancer

International Journal of Cancer. Journal International Du Cancer
Michael KlothWolfgang A Schulz

Abstract

Epigenetic aberrations are frequent in prostate cancer and could be useful for detection and prognostication. However, the underlying mechanisms and the sequence of these changes remain to be fully elucidated. The tumor suppressor gene RARRES1 (TIG1) is frequently hypermethylated in several cancers. Having noted changes in the expression of its paralogous neighbor gene LXN at 3q25.32, we used pyrosequencing to quantify DNA methylation at both genes and determine its relationship with clinicopathological parameters in 86 prostate cancer tissues from radical prostatectomies. Methylation at LXN and RARRES1 was highly correlated. Increasing methylation was associated with worse clinical features, including biochemical recurrence, and decreased expression of both genes. However, expression of three neighboring genes was unaffected. Intriguingly, RARRES1 methylation was influenced by the genotype of the rs6441224 single-nucleotide polymorphism (SNP) in its promoter. We found that this SNP is located within an ETS-family-response element and that the more strongly methylated allele confers lower activity in reporter assays. Concomitant methylation of RARRES1 and LXN in cancerous tissues was also detected in prostate cancer cell lines ...Continue Reading

References

Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·W H LeeW G Nelson
May 29, 2000·American Journal of Human Genetics·J S WitteW J Catalona
Apr 4, 2002·Journal of the National Cancer Institute·Chun JingYouqiang Ke
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Jan 29, 2003·Human Genetics·Tomohiko KayashimaTatsuya Kishino
Jun 19, 2003·Journal of the National Cancer Institute·Yutaka TokumaruDavid Sidransky
Feb 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael W Kattan
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eli RosenbaumDavid Sidransky
Dec 6, 2006·Cancer Research·Viswanathan MuthusamyMarcus Bosenberg
Jan 19, 2007·International Journal of Cancer. Journal International Du Cancer·Huiping ChenPaul J Goodfellow
Aug 30, 2008·PLoS Genetics·Yanis A BoumberJean-Pierre J Issa
Aug 7, 2009·Nature Reviews. Urology·Jeremy P Clark, Colin S Cooper
Sep 8, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Nicholas J HawkinsMegan P Hitchins
Nov 26, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·James DevaneySusan J Clark
Mar 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuguang LengSteven A Belinsky
Mar 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew Chase, Nicholas C P Cross
Jul 2, 2011·European Urology·Carmen JerónimoShahrokh F Shariat
Sep 24, 2011·Nature Reviews. Cancer·Stephen B Baylin, Peter A Jones

❮ Previous
Next ❯

Citations

Oct 3, 2014·Molecular Biology International·Gongcheng LiLong-Cheng Li
Sep 7, 2014·BMC Cancer·Nataša VasiljevićAttila T Lorincz
Dec 18, 2013·AIDS·Akihiro MatsunagaShotaro Hagiwara
Nov 25, 2017·Journal of Experimental & Clinical Cancer Research : CR·H HuebnerF B Fahlbusch
Apr 3, 2018·Current Opinion in Hematology·Cuiping Zhang, Ying Liang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Chang-Chieh WuShun-Yuan Jiang
International Journal of Cancer. Journal International Du Cancer
Huiping ChenPaul J Goodfellow
© 2021 Meta ULC. All rights reserved